» Articles » PMID: 17109331

Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines

Overview
Journal J Infect Dis
Date 2006 Nov 17
PMID 17109331
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Synthetic DNA vaccine strategies against persistent viral infections.

Villarreal D, Talbott K, Choo D, Shedlock D, Weiner D Expert Rev Vaccines. 2013; 12(5):537-54.

PMID: 23659301 PMC: 4317298. DOI: 10.1586/erv.13.33.


T-cell Epitopes Identified by BALB/c Mice Immunized with Vaccinia Expressing HIV-1 Gag lie within immunodominant Regions Recognized by HIV-infected Indian Patients.

Shete A, Thakar M, Tripathy S, Raut C, Chakrabarti S, Paranjape R J Glob Infect Dis. 2011; 3(3):246-53.

PMID: 21887056 PMC: 3162811. DOI: 10.4103/0974-777X.83530.


Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine.

Arrode-Bruses G, Sheffer D, Hegde R, Dhillon S, Liu Z, Villinger F J Virol. 2009; 84(3):1243-53.

PMID: 19923181 PMC: 2812351. DOI: 10.1128/JVI.01846-09.


Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine.

Arrode G, Hegde R, Jin Y, Singh D, Narayan O, Chebloune Y Vaccine. 2008; 26(31):3795-804.

PMID: 18586360 PMC: 2519121. DOI: 10.1016/j.vaccine.2008.05.057.


Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.

Rodriguez A, Goudsmit J, Companjen A, Mintardjo R, Gillissen G, Tax D Infect Immun. 2008; 76(4):1709-18.

PMID: 18212075 PMC: 2292849. DOI: 10.1128/IAI.01614-07.